Allogenic Bone-Marrow Mesenchymal Stromal Cell therapy

N/A

Report date: 2026/04/17 20:02:02

Base Information

Drug NameAllogenic Bone-Marrow Mesenchymal Stromal Cell therapy

Drug Alias NameHuman Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell therapyAllogeneic bone marrow (BM)-derived Mesenchymal Stromal Cell (MSC)

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsFrailty

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Arab Emirates

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCellcolabs Clinical SPV Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCellcolabs Clinical SPV Ltd

Inactive CompaniesN/A

Active IndicationsFrailty

Inactive IndicationsN/A

Other Information

ATC CodeN/A